Meyka AI API is live for developers.Start building.
Advertisement
Virios Therapeutics, Inc.

Virios Therapeutics, Inc. (VIRI) Stock Overview

Explore Virios Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

VIRI●NASDAQ
HealthcareBiotechnology
$0.15
$0.02(12.40%)
U.S. Market opens in 40h 11m
Advertisement

Virios Therapeutics, Inc. (VIRI)

Meyka AI Score

Z

Key Financials

Market Cap206.5K
P/E Ratio0.00
EPS (TTM)$-5.75
ROE286.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VIRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Virios Therapeutics, Inc. (VIRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 206.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-96.40%
1-Month Change
-95.51%
3-Month Change
-96.69%
6-Month Change
-98.50%
Year-to-Date (YTD) Change
-98.94%
1-Year Change
-99.11%
3-Year Change
-99.89%
5-Year Change
-99.96%
All-Time (Max) Change
-99.96%

Contact Information

https://www.virios.com
866 620 8655
44 Milton Avenue, Alpharetta, GA, 30009

Company Facts

40 Employees
IPO DateDec 17, 2020
CountryUS

Frequently Asked Questions